Here are nine cancer studies and research you might have missed:

Oncology leaders face many challenges in the field, and three in particular are top of mind: timeliness, treatment options and innovations.

Many agencies are delaying cancer trials and research due to cancer drug shortages, which may have a long-term effect on treatments, CNN reported July 20.

Richard Creech, MD, a pioneering medical oncologist, researcher and longtime leader, died July 1 of cancer at 83, The Philadelphia Inquirer reported July 19.

Nashville-based Tennessee Oncology announced plans to build a $120 million medical center in downtown Nashville, according to a July 19 report in The Tennessean. 

A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at University of Washington's Cancer Vaccine Institute and is preparing to move to phase 2, a July 17 Fred Hutchinson Cancer Center news release said.

Houston-based University of Texas MD Anderson Cancer Center has received a gift of  $16.25 million for brain cancer and neuroscience research, according to a July 18 news release shared with Becker's. 

Clinicians are using robot-assisted technology to diagnose and treat lung cancer in a same-day procedure at Baptist Health Paducah (Ky.) and four other system hospitals.

Michael Postow, MD, chief of melanoma service at Memorial Sloan Kettering Cancer Center in New York City, picked oncology because it was a place where he could make the biggest impact.

Detroit-based Barbara Ann Karmanos Cancer Institute named Arnold D'Ambrosio chief development officer, effective July 10.

Here are the top four cancer hospitals in North Dakota, according to U.S. News & World Report rankings.

A World Health Organization analysis classified non-sugar sweetener aspartame as possibly carcinogenic to humans, but the FDA disagrees with the assessment.

Seattle-based Fred Hutchinson Cancer Center is working to close a gap in communications between physicians and patients about their pain.

A research letter spearheaded by an associate professor at the UT Health Houston School of Public Health argues that those who had cancer have similar survival rates as new cancer cases, and prior cancer should not be grounds to exclude a patient from clinical trials.

Researchers at Boston-based Mass General Cancer Center found a treatment that reduced a rare type of brain tumor by an average of 91 percent in a clinical trial.

Preoperative magnetic resonance imaging does not "significantly reduce positive margins" following breast-conserving surgery, according to trial study findings published July 10 in The Asco Post.

Luis Diaz Jr., MD, was one of the researchers who led a 2022 clinical trial of a specific type of rectal cancer with a 100 percent success rate, Fast Company reported July 6.

Here are the top five cancer hospitals in Texas, according to U.S. News & World Report rankings:

Lebanon, N.H.-based Dartmouth Health has stayed ahead of the cancer drug shortages thanks in part to its supply chain strategy, officials told The Keene Sentinel July 8.

Thirty-eight oncologists made Castle Connolly's list of top Asian American and Pacific Islander physicians.